StreetInsider.com News Articles

Form SCHEDULE 13G/A Burning Rock Biotech Filed by: Kynam Capital Management, LP

Fri, 15 May 2026 16:02:00 -0400

si-local-file:///var/storage/secattach/20260515/26504690.html

Form SCHEDULE 13G/A Burning Rock Biotech Filed by: Kynam Capital Management, LP

Fri, 15 May 2026 16:02:00 -0400

si-local-file:///var/storage/secattach/20260515/26504690.html

Form SCHEDULE 13G/A Burning Rock Biotech Filed by: CRCM LP

Wed, 13 May 2026 17:12:00 -0400

si-local-file:///var/storage/secattach/20260513/26487465.html

Form SCHEDULE 13G/A Burning Rock Biotech Filed by: CRCM LP

Wed, 13 May 2026 17:12:00 -0400

si-local-file:///var/storage/secattach/20260513/26487465.html

Burning Rock Publishes 2025 Annual Report on Form 20-F

Tue, 28 Apr 2026 06:45:00 -0400

GUANGZHOU, China, April 28, 2026 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing technology in the field of precision oncology, announces that on April 28, 2026 it filed its Annual Report on Form 20-F for the year ended December 31, 2025 (the “Form 20-F”) with the U.S. Securities and Exchange Commission (“SEC”). The Form 20-F is available for viewing on the SEC website at www.sec.gov and also on the Company’s website at http://ir.brbiotech.com. The

Burning Rock Publishes 2025 Annual Report on Form 20-F

Tue, 28 Apr 2026 06:45:00 -0400

Burning Rock Publishes 2025 Annual Report on Form 20-F

Tue, 28 Apr 2026 06:45:00 -0400

Burning Rock Publishes 2025 Annual Report on Form 20-F

Tue, 28 Apr 2026 06:45:00 -0400

Burning Rock Publishes 2025 Annual Report on Form 20-F

Tue, 28 Apr 2026 06:45:00 -0400

Burning Rock Publishes 2025 Annual Report on Form 20-F

Tue, 28 Apr 2026 06:45:00 -0400

Form 20-F Burning Rock Biotech For: Dec 31

Tue, 28 Apr 2026 06:11:00 -0400

si-local-file:///var/storage/secattach/20260428/26377727.html

Form 20-F Burning Rock Biotech For: Dec 31

Tue, 28 Apr 2026 06:11:00 -0400

si-local-file:///var/storage/secattach/20260428/26377727.html

Form 4 Burning Rock Biotech For: Mar 31 Filed by: Han Yusheng

Thu, 02 Apr 2026 07:18:00 -0400

si-local-file:///var/storage/secattach/20260402/26262462.html

Form 4 Burning Rock Biotech For: Mar 31 Filed by: Han Yusheng

Thu, 02 Apr 2026 07:18:00 -0400

si-local-file:///var/storage/secattach/20260402/26262462.html

Burning Rock founder purchases $1.4 million in company shares

Thu, 02 Apr 2026 06:26:49 -0400

Burning Rock Biotech Limited (NASDAQ: BNR) announced that founder and CEO Yusheng Han purchased 31,487 American depositary shares for $546,603.90 through open market transactions.

The purchase brings Han's total acquisition to 72,733 ADSs worth $1,358,325.18 across two consecutive post-earnings trading windows, according to a company statement. The transactions were conducted in compliance with applicable regulations and the company's insider trading policy.

Burning Rock, based in Guangzhou, China, focuses on next generation sequencing technology applications in precision oncology. The company operates two main business segments: NGS-based therapy selection testing for late-stage cancer patients and cancer early detection programs.

Han may continue purchasing company shares

Burning Rock founder purchases $1.4 million in company shares

Thu, 02 Apr 2026 06:26:49 -0400

Burning Rock Biotech Limited (NASDAQ: BNR) announced that founder and CEO Yusheng Han purchased 31,487 American depositary shares for $546,603.90 through open market transactions.

Han may continue purchasing company shares

Burning Rock Announces Founder’s Purchase of Its ADSs